She could die, Lana says
Semaglutide (SEM-a-gloo-tide) A synthetic GLP-1 receptor agonist developed from exendin-4
Kalianin, D., Bri, L., Ljubeti, K., Bari, A., Graan, S., Brekalo, M., & Boraska Perica, V
Importantly, in one study, nearly three-quarters of participants with prediabetes returned to normal blood sugar levels, suggesting that retatrutide may help not only manage but even reverse early metabolic dysfunction
If symptoms suggestive of thyroid dysfunction develop during semaglutide treatment, thyroid function tests should be obtained promptly rather than waiting for routine monitoring intervals
Statements Author contributions WL: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing original draft, Writing review and editing